Please try another search
MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally. The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food. It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis. In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia. Further, the company develops SMUP-IA-01 to treat osteoarthritis; and SMUP-IV-01 for the treatment of diabetic nephropathy. Additionally, it offers nutritional and dietary supplements under the MOVITA brand name; and CDMO services. The company was founded in 2000 and is headquartered in Seongnam-si, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Hye-Kyung Hong | 55 | - | Director of 1st Research Department and Director |
Soo-Jin Choi | 53 | - | Director of Research Department and Director |
Won-II Oh | 62 | - | General Director of Laboratory, Vice President and Director |
Young-Hwan Song | 58 | - | Head Manager of Management Support Division and Director |
Sung-Ho Han | 54 | - | Head Manager of Business Development Division and Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review